EPISODE · Jul 6, 2026 · 16 MIN
232: An Interview With John MacMahon, CEO of CytoKind, on the Benefits of Artificial Sunlight
from Rare Care Podcast · host Rare Care Podcast
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews John MacMahon, a New Hampshire-based medical devices company that specializes in phototherapy to treat fatigue in people with multiple sclerosis.
NOW PLAYING
232: An Interview With John MacMahon, CEO of CytoKind, on the Benefits of Artificial Sunlight
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m